GLP1R and type 1 diabetes mellitus: Further GLP1-RAs used in T1D are being investigated in the DIAMOND GLP1 (NCT03668470) study (dulaglutide versus placebo), and the TTT1 (NCT03899402) trial (subcutaneous semaglutide, dapagliflozin, or combination versus placebo).